About to go booom, page-17

Well maybe your broker has a short memory or is not even aware that between 2008 and 2010 MSB went from 0.50c to $10 long before anything was even close to being proven or phase 1 trials even commenced . That took their market cap well over $2 billion, and that was 6-8 years before any product was approved or any sale made.... and today they still have a massive market cap despite the fact their manufacturing process is not anywhere near as scalable or clinically robust as CYP.

So the market will run with it at any time, when products are approved and go on sale its already game over as far as the shareprice is concerned

the Japanese, the Germans , the yanks., they all know the science behind Cymerus works, they are not waiting for anything anymore, deals are happening and others will either sit up and take notice or be left behind as also rans trying to collect and shove a barrow full of bone marrow cells, trying to sell medicines for $200,000 that those using Cymerus will sell for a fraction of that to many more recipients

the commercialty for CYP licensing out the technology is here now, who knows how many licensing deals are done within 12-18 months... the tipping point will come out of the blue, probably when investors with deep pockets who have not even heard of CYP today realise that anything under $2 is far too cheap